CRESUD S.A.-SPONS ADR (CRESY)

US2264061068 - ADR

6.85  -0.05 (-0.72%)

Fundamental Rating

4

Taking everything into account, CRESY scores 4 out of 10 in our fundamental rating. CRESY was compared to 92 industry peers in the Food Products industry. CRESY has an excellent profitability rating, but there are concerns on its financial health. CRESY is quite expensive at the moment. It does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

The reported net income has been mixed in the past 5 years: CRESY reported negative net income in multiple years.
Of the past 5 years CRESY 4 years had a positive operating cash flow.

1.2 Ratios

CRESY's Return On Assets of 4.94% is fine compared to the rest of the industry. CRESY outperforms 60.87% of its industry peers.
The Return On Equity of CRESY (25.38%) is better than 93.48% of its industry peers.
CRESY has a Return On Invested Capital (3.09%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRESY is significantly below the industry average of 8.54%.
The last Return On Invested Capital (3.09%) for CRESY is above the 3 year average (1.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.94%
ROE 25.38%
ROIC 3.09%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.24%
ROIC(5y)1.35%

1.3 Margins

CRESY's Profit Margin of 20.47% is amongst the best of the industry. CRESY outperforms 97.83% of its industry peers.
In the last couple of years the Profit Margin of CRESY has grown nicely.
With an excellent Operating Margin value of 13.21%, CRESY belongs to the best of the industry, outperforming 83.70% of the companies in the same industry.
CRESY's Operating Margin has improved in the last couple of years.
CRESY has a Gross Margin of 39.09%. This is amongst the best in the industry. CRESY outperforms 94.57% of its industry peers.
CRESY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.21%
PM 20.47%
GM 39.09%
OM growth 3Y-15.85%
OM growth 5Y6.83%
PM growth 3Y23.52%
PM growth 5Y27.63%
GM growth 3Y3.55%
GM growth 5Y2.3%

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CRESY has been reduced compared to 1 year ago.
The number of shares outstanding for CRESY has been increased compared to 5 years ago.
CRESY has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of CRESY is 20.75, which is on the high side as it means it would take CRESY, 20.75 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.75, CRESY perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
A Debt/Equity ratio of 0.85 indicates that CRESY is somewhat dependend on debt financing.
The Debt to Equity ratio of CRESY (0.85) is worse than 65.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 20.75
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.08 indicates that CRESY should not have too much problems paying its short term obligations.
With a Current ratio value of 1.08, CRESY is not doing good in the industry: 79.35% of the companies in the same industry are doing better.
CRESY has a Quick Ratio of 1.08. This is a bad value and indicates that CRESY is not financially healthy enough and could expect problems in meeting its short term obligations.
CRESY has a Quick ratio (0.84) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.84

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.97% over the past year.
CRESY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.10% yearly.
The Revenue has grown by 102.55% in the past year. This is a very strong growth!
Measured over the past years, CRESY shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y31.97%
EPS 3Y50.93%
EPS 5Y42.1%
EPS growth Q2Q42.57%
Revenue growth 1Y102.55%
Revenue growth 3Y32.29%
Revenue growth 5Y15.34%
Revenue growth Q2Q106.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CRESY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

CRESY has a Yearly Dividend Yield of 2.74%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.68, CRESY pays a bit more dividend than its industry peers.
CRESY's Dividend Yield is comparable with the S&P500 average which is at 2.64.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

CRESY has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

83.07% of the earnings are spent on dividend by CRESY. This is not a sustainable payout ratio.
DP83.07%
EPS Next 2YN/A
EPS Next 3YN/A

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (9/22/2023, 7:00:01 PM)

6.85

-0.05 (-0.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)09-05 2023-09-05/bmo
Earnings (Next)11-09 2023-11-09/bmo
Inst Owners10.92%
Inst Owner Change11.17%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap401.44M
Analysts86.67
Price Target7.28 (6.28%)
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Dividend Growth(5Y)N/A
DP83.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)-32.32%
PT rev (3m)-50.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.94%
ROE 25.38%
ROCE 3.92%
ROIC 3.09%
ROICexc 3.42%
ROICexgc 3.46%
OM 13.21%
PM 20.47%
GM 39.09%
FCFM 5.34%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.24%
ROIC(5y)1.35%
ROICexc(3y)1.39%
ROICexc(5y)1.65%
ROICexgc(3y)1.41%
ROICexgc(5y)1.71%
ROCE(3y)1.56%
ROCE(5y)1.71%
ROICexcg growth 3Y-1.05%
ROICexcg growth 5Y4.58%
ROICexc growth 3Y1.02%
ROICexc growth 5Y5.48%
OM growth 3Y-15.85%
OM growth 5Y6.83%
PM growth 3Y23.52%
PM growth 5Y27.63%
GM growth 3Y3.55%
GM growth 5Y2.3%
F-Score7
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 20.75
Debt/EBITDA 4.82
Cap/Depr 690.77%
Cap/Sales 7.2%
Profit Quality 26.08%
Current Ratio 1.08
Quick Ratio 0.84
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)426.25%
Cap/Depr(5y)352.8%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y31.97%
EPS 3Y50.93%
EPS 5Y42.1%
EPS growth Q2Q42.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y102.55%
Revenue growth 3Y32.29%
Revenue growth 5Y15.34%
Revenue growth Q2Q106.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y451.95%
EBIT growth 3Y11.32%
EBIT growth 5Y23.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.5%
FCF growth 3Y-45.11%
FCF growth 5Y-1.78%
OCF growth 1Y8%
OCF growth 3Y-28.07%
OCF growth 5Y6.78%